跳至主要内容
临床试验/NCT07169695
NCT07169695招募中2 期

Efficacy and Safety Assessment of T1695 Ophthalmic Suspension, Versus Ciclosporin Ophthalmic Emulsion, in Participants With Moderate to Severe Vernal Keratoconjunctivitis (VKC)

Laboratoires Thea11 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年3月24日最近更新:
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
120
试验地点
11
主要终点
Change from baseline (Day 1) at Day 29 (Week 4) in Corneal Fluorescein Staining (CFS) grade assessed by the (0-5) modified Oxford scale in the study eye.

研究概览

简要总结

The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Main Inclusion Criteria:
  • Informed consent signed and dated
  • Male or female participant from 4 years to less than 18 years old.
  • Participant with grading score of 3 or 4 on the Bonini scale for clinical grading of VKC in each eye.

排除标准

  • Participants must not have any conditions which might exclude them from participating, could interfere with the study, or pose an unacceptable risk to their health.

研究组 & 干预措施

T1695

Experimental

The participant should instill T1695.

干预措施: Slit Lamp Examination (Diagnostic Test)

Ciclosporin

Active Comparator

The participant should instill Ciclosporin.

干预措施: Ciclosporin (Drug)

T1695

Experimental

The participant should instill T1695.

干预措施: Far Best Corrected Visual Acuity (BCVA) (Diagnostic Test)

T1695

Experimental

The participant should instill T1695.

干预措施: T1695 (Drug)

T1695

Experimental

The participant should instill T1695.

干预措施: Corneal fluorescein staining score on modified Oxford scale (Diagnostic Test)

Ciclosporin

Active Comparator

The participant should instill Ciclosporin.

干预措施: Slit Lamp Examination (Diagnostic Test)

Ciclosporin

Active Comparator

The participant should instill Ciclosporin.

干预措施: Far Best Corrected Visual Acuity (BCVA) (Diagnostic Test)

Ciclosporin

Active Comparator

The participant should instill Ciclosporin.

干预措施: Corneal fluorescein staining score on modified Oxford scale (Diagnostic Test)

结局指标

主要结局

Change from baseline (Day 1) at Day 29 (Week 4) in Corneal Fluorescein Staining (CFS) grade assessed by the (0-5) modified Oxford scale in the study eye.

时间窗: From Day 1 to Day 29

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验